Due to the infancy of this niche sector, followed by the first handful of market authorisations and a subsequent major surge of new investor interest in the last few years, there has been a dramatic spike in ATMP & Rare Disease start-ups in recent times.
This is indicative of a positively emerging sector, however it does also mean that there is a phenomenal and problematic gap in the supply:demand for pioneers and leadership expertise with business-critical experience in this space.
Whilst hiring people familiar with these nuanced landscapes is crucial to success, these networks are extremely fragile. Limited and over-approached talent pools make it extremely challenging to identify, attract and secure the best in industry.
Traditional recruitment methods, used when sourcing from larger talent pools, do not always work well in these sensitive, low-prevalence communities. They can easily lead to them being overlooked or alienated, much to the detriment of your business – and the patients we serve.
This is where Mendel Partners can help. Leveraging our expert knowledge within this space, alongside our especially developed Advanced Therapies and Rare Disease focused Leadership portfolio, deep research-led recruitment methods and highly personalised sourcing tactics; we can help you recruit boards and leadership teams that will make the most meaningful impact to your business, and the patients and shareholders you serve.
